12:50 PM EDT, 06/27/2025 (MT Newswires) -- INmune Bio ( INMB ) plans to sell 3 million shares of common stock at $6.30 each in a registered direct offering to two undisclosed institutional investors focused on health care, raising $19 million in gross proceeds.

The offering is expected to close Monday, the company said Friday in a statement.

Proceeds are intended for working capital and general corporate purposes.

Shares of the company fell 9.2% in recent trading Friday.

Price: 5.70, Change: -0.58, Percent Change: -9.24